Vessel co-option in primary human tumors and metastases: an obstacle to effective anti-angiogenic treatment? by Donnem, T, Hu, J, Ferguson, M, Adighibe, O, Snell, C, Harris, A, Gatter, K, Pezzella, F

Why some tumours trigger neovascularisation and others don’t: the story thus far by Adighibe, O, Leek, R, Fernandez-Mercado, M, Hu, J, Snell, C, Gatter, K, Harris, A, Pezzella, F

microRNA-associated progression pathways and potential therapeutic targets identified by integrated mRNA and microRNA expression profiling in breast cancer by Buffa, F, Camps, C, Winchester, L, Snell, C, Gee, H, Sheldon, H, Taylor, M, Harris, A, Ragoussis, J

microRNA-associated progression pathways and potential therapeutic targets identified by integrated mRNA and microRNA expression profiling in breast cancer. by Buffa, F, Camps, C, Winchester, L, Snell, C, Gee, H, Sheldon, H, Taylor, M, Harris, A, Ragoussis, J

Proline-hydroxylated hypoxia-inducible factor 1a (HIF-1a) upregulation in human tumours by Snell, C, Turley, H, McIntyre, A, Li, D, Masiero, M, Schofield, C, Gatter, K, Harris, A, Pezzella, F

PAT4 levels control amino-acid sensitivity of rapamycin-resistant mTORC1 from the Golgi and affect clinical outcome in colorectal cancer by Fan, S, Snell, C, Turley, H, Li, J, McCormick, R, Perera, S, Heublein, S, Kazi, S, Azad, A, Wilson, C, Harris, A, Goberdhan, D

Immunologic aspects of chronic fatigue syndrome. Report on a Research Symposium convened by The CFIDS Association of America and co-sponsored by the US Centers for Disease Control... by Gerrity, T, Papanicolaou, D, Amsterdam, J, Bingham, S, Grossman, A, Hedrick, T, Herberman, R, Krueger, G, Levine, S, Mohagheghpour, N, Moore, R, Oleske, J, Snell, C

Carbonic anhydrase IX promotes tumor growth and necrosis in vivo and inhibition enhances anti-VEGF therapy. by McIntyre, A, Patiar, S, Wigfield, S, Li, J, Ledaki, I, Turley, H, Leek, R, Snell, C, Gatter, K, Sly, W, Vaughan-Jones, R, Swietach, P, Harris, A

Glucose utilization via glycogen phosphorylase sustains proliferation and prevents premature senescence in cancer cells. by Favaro, E, Bensaad, K, Chong, MG, Tennant, D, Ferguson, D, Snell, C, Steers, G, Turley, H, Li, J, Günther, U, Buffa, F, McIntyre, A, Harris, A

Disrupting hypoxia-induced bicarbonate transport acidifies tumor cells and suppresses tumor growth by McIntyre, A, Hulikova, A, Ledaki, I, Snell, C, Singleton, D, Steers, G, Seden, P, Jones, D, Bridges, E, Wigfield, S, Li, J, Russell, A, Swietach, P, Harris, A

Reciprocal expression of the endocytic protein HIP1R and its repressor FOXP1 predicts outcome in R-CHOP-treated diffuse large B-cell lymphoma patients by Wong, K, Gascoyne, D, Brown, P, Soilleux, E, Snell, C, Chen, H, Lyne, L, Lawrie, C, Gascoyne, R, Pedersen, L, Møller, M, Pulford, K, Murphy, D, Green, T, Banham, A

Reciprocal expression of the endocytic protein HIP1R and its repressor FOXP1 predicts outcome in R-CHOP-treated diffuse large B-cell lymphoma patients. by Wong, K, Gascoyne, D, Brown, P, Soilleux, E, Snell, C, Chen, H, Lyne, L, Lawrie, C, Gascoyne, R, Pedersen, L, Møller, M, Pulford, K, Murphy, D, Green, T, Banham, A

Characterising ¹⁸F-fluciclovine uptake in breast cancer through the use of dynamic PET/CT imaging by Scott, NP, Teoh, EJ, Flight, H, Jones, BE, Niederer, J, Mustata, L, MacLean, GM, Roy, PG, Remoundos, DD, Snell, C, Liu, C, Gleeson, FV, Harris, AL, Lord, SR, McGowan, DR

DLL4-Notch signaling mediates tumor resistance to anti-VEGF therapy in vivo. by Li, J, Sainson, R, Oon, C, Turley, H, Leek, R, Sheldon, H, Bridges, E, Shi, W, Snell, C, Bowden, E, Wu, H, Chowdhury, P, Russell, A, Montgomery, C, Poulsom, R, Harris, A

DLL4-Notch Signaling Mediates Tumor Resistance to Anti-VEGF Therapy In Vivo by Li, J, Sainson, R, Oon, C, Turley, H, Leek, R, Sheldon, H, Bridges, E, Shi, W, Snell, C, Bowden, E, Wu, H, Chowdhury, P, Russell, A, Montgomery, C, Poulsom, R, Harris, A

Integrated pharmacodynamic analysis identifies two metabolic adaption pathways to metformin in breast cancer by Lord, S, Cheng, WC, Liu, D, Gaude, E, Haider, S, Patel, N, Teoh, E, Gleeson, F, Mcgowan, D, Thompson, A, Ah-See, ML, Snell, C, Ayers, L, Karpe, F, Pollak, M, Frezza, C, Fenwick, J, Buffa, F, Harris, A

A core human primary tumor angiogenesis signature identifies the endothelial orphan receptor ELTD1 as a key regulator of angiogenesis. by Masiero, M, Simões, F, Han, H, Snell, C, Peterkin, T, Bridges, E, Mangala, L, Wu, S, Pradeep, S, Li, D, Han, C, Dalton, H, Lopez-Berestein, G, Tuynman, J, Mortensen, N, Li, J, Patient, R, Sood, A, Banham, A, Harris, A, Buffa, F

A core human primary tumor angiogenesis signature identifies the endothelial orphan receptor ELTD1 as a key regulator of angiogenesis by Masiero, M, Simões, F, Han, H, Snell, C, Peterkin, T, Bridges, E, Mangala, L, Wu, S, Pradeep, S, Li, D, Han, C, Dalton, H, Lopez-Berestein, G, Tuynman, J, Mortensen, N, Li, J, Patient, R, Sood, A, Banham, A, Harris, A, Buffa, F

Resolving the ancestry of Austronesian-speaking populations by Soares, P, Trejaut, J, Rito, T, Cavadas, B, Hill, C, Eng, K, Mormina, M, Brandão, A, Fraser, R, Wang, T, Loo, J, Snell, C, Ko, T, Amorim, A, Pala, M, Macaulay, V, Bulbeck, D, Wilson, J, Gusmão, L, Pereira, L, Oppenheimer, S, Lin, M, Richards, M

Integrated pharmacodynamic analysis identifies two metabolic adaption pathways to metformin in breast cancer by Lord, S, Cheng, W, Liu, D, Gaude, E, Haider, S, Metcalf, T, Patel, N, Teoh, E, Gleeson, F, Bradley, K, Wigfield, S, Zois, C, McGowan, D, Ah-See, M, Thompson, A, Sharma, A, Bidaut, L, Pollak, M, Roy, P, Karpe, F, James, T, English, R, Adams, R, Campo, L, Ayers, L, Snell, C, Roxanis, I, Frezza, C, Fenwick, J, Buffa, F, Harris, A